Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Molecular Biology|February 21, 2009
Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexesYong Chen, Feng Gao, Fuliang Chu, et al.
Emerging Infectious Diseases|June 18, 2004
Genetic variation of SARS coronavirus in Beijing HospitalDongping Xu, Zheng Zhang, Fuliang Chu, et al.
The Journal of Infectious Diseases|September 14, 2010
The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopesJun Liu, Yeping Sun, Jianxun Qi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escapeFuliang Chu, Zhiyong Lou, Yu Wai Chen, et al.
Science Signaling|September 29, 2016
Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cellsHaiyan S Li, Chengwen Liu, Yichuan Xiao, et al.
Blood|May 31, 2012
TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomasJinsheng Weng, Seema Rawal, Fuliang Chu, et al.
Research Square|February 24, 2023
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatmentShuying Liu, Shelly M Xie, Wenbin Liu, et al.
Oncoimmunology|January 27, 2017
IL-15 enhances the antitumor effect of human antigen-specific CD8<sup>+</sup> T cells by cellular senescence delayJinsheng Weng, Kelsey E Moriarty, Flavio Egidio Baio, et al.
Nature Medicine|July 26, 2011
Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactionsYeonseok Chung, Shinya Tanaka, Fuliang Chu, et al.
Breast Cancer Research : BCR|June 6, 2023
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatmentShuying Liu, Shelly M Xie, Wenbin Liu, et al.
Pageof 3